Urine 2-Hydroxyglutarate in Glioma

Giuseppe Lombardi; Alessandro Della Puppa; Vittorina Zagonel

doi:10.1634/theoncologist.2016-0123

Urine 2-Hydroxyglutarate in Glioma

Oncologist. 2016 Aug;21(8):1026. doi: 10.1634/theoncologist.2016-0123.

Authors

Giuseppe Lombardi¹, Alessandro Della Puppa², Vittorina Zagonel³

Affiliations

¹ Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology, Istituto Di Ricovero e Cura a Carattere Scientifico, Padua, Italy giuseppe.lombardi@ioveneto.it.
² Neurosurgery Department, Azienda Ospedale Padova, Padua, Italy.
³ Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology, Istituto Di Ricovero e Cura a Carattere Scientifico, Padua, Italy.

Abstract

This letter compares the results of two studies on the oncometabolite 2-hydroxyglutarate in patients with isocitrate dehydrogenase (IDH) mutant and IDH wild-type glioma.

Publication types

Letter
Comment

MeSH terms

Brain Neoplasms
Glioma*
Glutarates*
Humans
Isocitrate Dehydrogenase / genetics
Mutation

Substances

Glutarates
alpha-hydroxyglutarate
Isocitrate Dehydrogenase